How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,522 results for

Tobacco Cessation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness

Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost (...) -Effectiveness Last updated: September 9, 2019 Project Number: RC1174-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of pharmacist-led tobacco smoking cessation interventions? What is the cost-effectiveness of pharmacist-led tobacco smoking cessation interventions versus self-directed smoking cessation interventions? Key Message Three systematic reviews were identified regarding the clinical

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Tobacco and Nicotine Cessation During Pregnancy

Tobacco and Nicotine Cessation During Pregnancy Tobacco and Nicotine Cessation During Pregnancy | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Tobacco and Nicotine Cessation During Pregnancy Committee Opinion Number 807 May 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . Pregnancy influences many women to stop smoking, and approximately 54% of women (...) in tobacco cessation begins with a brief counseling session. The 5A’s intervention is effective when initiated by health care professionals . With appropriate training, obstetrician–gynecologists, family physicians, other clinicians, or auxiliary health care professionals can perform these five steps with pregnant women who smoke . Referral to a tobacco quit line may further benefit the patient. Quit lines offer information, direct support, and ongoing counseling that help women quit smoking and remain

2020 American College of Obstetricians and Gynecologists

5. Tobacco Cessation

Flexible Quit Dates. Nicotine & Tobacco Research. 2012. 14(3):343-350. RxFiles. Tobacco / Smoking Cessation Pharmacotherapy. 2012. Available at . Pharmacotherapy for Smoking Cessation in Adults. 2012. Zwar N, et al. Nicotine and nicotine replacement therapy – the facts. Australian Pharmacist. 2006;25(12):969-973. Fagerstrom K, et al. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ. 2010;341:c6549. Aubin H, et al. Weight gain in smokers after quitting (...) suggested, but if the patient is not interested, you may still prescribe treatment. While varenicline has the highest quit rates, therapy should be tailored to the individual’s needs and preferences. (Level 1C Recommendation) Combination pharmacotherapy may be warranted in cases of previous unsuccessful attempts with monotherapy, or patient preference. 1. Non-pharmacological treatments for tobacco cessation: Counseling and psychosocial support programs (e.g. ) . Cognitive Behavioral Therapy Motivational

2019 medSask

6. Tobacco Cessation Treatment

. For treatment purposes, virtually all persistent daily smokers are nicotine dependent and are likely to bene?tfrom JACC VOL. -,NO. -,2018 Barua et al. -,2018:-–- Tobacco Cessation Treatment Pathway 7pharmacological and behavioral treatment for smoking cessation. Nondaily smokers, some of whom previ- ously smoked every day, may not have withdrawal symptoms when stopping tobacco use, but they may use cigarettes compulsively in certain situations and have great dif?culty quitting. They should also be advised (...) tobacco cessation program, if available, or free resources provided by telephone (e.g., 1-800-QUIT NOW) or online (e.g., www.smokefree.gov, Becomeanex.org). The patient should leave the visit with asetoffreely availableresourcesand aplanandtimeline foraccessingthereferredbehavioraltherapy(Table2).For current smokers who decline the offer of treatment at the visit, treatments should be offered again at every subse- quent visit because the motivationto stop smoking varies over time. 4. Follow-Up

2019 American College of Cardiology

7. Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines

regarding the clinical effectiveness of integrated cessation programs in adults who smoke cannabis and tobacco. Tags cannabinoids, cannabis, endocannabinoids, marijuana abuse, marijuana smoking, nicotine, receptors, cannabinoid, smoking, smoking cessation, tobacco, tobacco use cessation products, tobacco use disorder, addiction, other miscellaneous topics, Cigarette, Cigarettes, marihuana, marijuana, Cannabinoid, tetrahydrocannabinoid, quitting, quitting smoking, Reduce, reduction, discontinue (...) Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Published

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

8. Secure Asynchronous Communication Between Smokers and Tobacco Treatment Specialists: Secondary Analysis of a Web-Assisted Tobacco Intervention in the QUIT-PRIMO and National Dental PBRN Networks. Full Text available with Trip Pro

Secure Asynchronous Communication Between Smokers and Tobacco Treatment Specialists: Secondary Analysis of a Web-Assisted Tobacco Intervention in the QUIT-PRIMO and National Dental PBRN Networks. Within a web-assisted tobacco intervention, we provided a function for smokers to asynchronously communicate with a trained tobacco treatment specialist (TTS). Previous studies have not attempted to isolate the effect of asynchronous counseling on smoking cessation.This study aimed to conduct (...) their previous use of nicotine replacement therapy and medications; 201/565, 35.6%). The majority of TTS messages used behavioral strategies (233/517, 45.1%), offered advice on treatments (189/517, 36.5%), and highlighted motivations to quit (171/517, 33.1%). There was no association between the amount of TTS use and cessation. In the multivariable model, after adjusting for gender, age, race, education, readiness at baseline, number of cigarettes smoked per day at baseline, and the selected TTS, smokers

2020 Journal of medical Internet research

9. Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Tobacco use is the leading cause of preventable death in the US. An estimated annual 480 000 deaths are attributable to tobacco use in adults, including from secondhand smoke. It is estimated that every day about 1600 youth aged 12 to 17 years smoke their first cigarette and that about 5.6 million adolescents alive today will die (...) brain function and cognition, attention, and mood; thus, minimizing nicotine exposure from any tobacco product in youth is important.To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on the benefits and harms of primary care interventions for tobacco use prevention and cessation in children and adolescents. The current systematic review newly included e-cigarettes as a tobacco product.This recommendation applies to school-aged children and adolescents younger than

2020 JAMA

10. WHO monograph on tobacco cessation and oral health integration

WHO monograph on tobacco cessation and oral health integration WHO monograph on tobacco cessation and oral health integration JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO monograph on tobacco cessation and oral health integration View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO monograph on tobacco cessation and oral

2017 WHO

11. Varenicline and Counseling for Patients Seeking to Stop Using Smokeless Tobacco May Lead to Higher Rates of Long-Term Abstinence Than Chairside Counseling Alone

seeking to stop using smokeless tobacco, do medicinal therapies lead to higher rates of cessation than just chairside counseling in the dental office? Clinical Bottom Line Based on the systematic reviews cited, there is evidence that a combination of varenicline (Chantix) and chairside counseling will lead to the highest rate of sustained tobacco abstinence. Two systematic reviews showed that there is a benefit to some type of tobacco cessation counseling. Among the studies that used varenicline (...) of chairside counseling could help narrow down what type of counseling has the highest efficacy. The large amount of heterogeneity found at the 26-week mark for the third systematic review limits the interpretation of this aspect of the study. The differences in the results for the long-term efficacy of varenicline on smokeless tobacco cessation may warrant more research or a different inclusion/exclusion criteria for a systematic review. Applicability Dentists treating patients seeking to stop using

2017 UTHSCSA Dental School CAT Library

12. User characteristics of national smoking cessation services in Korea: who chooses each type of tobacco cessation program? Full Text available with Trip Pro

User characteristics of national smoking cessation services in Korea: who chooses each type of tobacco cessation program? Relatively little is known about which characteristics of smokers are related to choosing a specific type of smoking cessation service. The user characteristics of different smoking cessation services were compared to determine the service preferred by user characteristics.The characteristics of adult smokers from Korea National Health and Nutrition Examination Survey (3762 (...) ) and registered users of national smoking cessation services operated through the web (14,762), at Public Health Center-based Smoking Cessation Clinics (PHC-based SCCs) (335,532), and by telephone (Quitline) (2983) were compared.Females and younger aged were more in web and telephone-based cessation service users, while aged 50 years or older were more in PHC-based SCCs users. Although manufacturing and production workers were the most prevalent among smokers in the general population, office workers

2019 BMC health services research

13. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke. Full Text available with Trip Pro

Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke. To determine the cost-effectiveness of an incentive-based stop-smoking intervention that paid Medicaid recipients who smoke to take calls from a tobacco quit line.A cost-effectiveness analysis was conducted alongside a randomized controlled trial. The analysis was conducted from a health care systems perspective on the basis of costs and effectiveness over (...) of the financial incentives intervention was $2316 (95% confidence interval $1582-$4270) per additional person who quit. The study ICER compares favorably with other smoking treatments, such as varenicline combined with proactive telephone counseling, whose ICER has been estimated at $2600 per additional smoker who quits.Use of financial incentives to engage with tobacco quit line treatment is a cost-effective option to enhance smoking cessation rates for low-income smokers.Copyright © 2019 ISPOR

2019 Value in Health Controlled trial quality: uncertain

14. Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates. (Abstract)

of 0.32 had a 100% sensitivity and 45% specificity for tobacco use resumption. Thirty-five percent of the post-transplant tobacco users successfully quit tobacco consumption.Patients with COPD and a short duration of smoking cessation prior to LTx were at greatest risk of tobacco use after LTx. The packyear-cessation index may be a useful predictor of tobacco use resumption. Pharmacological tobacco cessation interventions were found to have a comparable safety and efficacy profile compared to non (...) Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates. Smoking remains the leading cause of preventable disease and death in the developed world that kills half of all long-term users. Tobacco use after solid organ transplantation is associated with allograft dysfunction, cancer, and reduced overall survival.In this single-center, retrospective study, we describe the frequency of tobacco use after

2019 Transplantation

15. Impact of a tobacco cessation intervention on adherence to tobacco use treatment guidelines among village health workers in Vietnam. (Abstract)

Impact of a tobacco cessation intervention on adherence to tobacco use treatment guidelines among village health workers in Vietnam. Community health workers (in Vietnam referred to as village health workers) have the potential to play a key role in expanding access to evidence-based tobacco use treatment. We conducted a cluster randomized controlled trial in community health centers in Vietnam that compared the effect of provider advice and cessation assistance (i.e. brief counseling (...) and patient education materials) (BC) vs. BC + three sessions of in-person counseling delivered by a village health worker (BC+R) on providers' and village health workers' adherence to tobacco use treatment guidelines. All village health workers and health care providers received training. This paper presents data on the effect of the intervention on village health workers' adherence to tobacco use treatment guidelines, including asking about tobacco use, advising smokers to quit, offering assistance

2019 Global health promotion Controlled trial quality: uncertain

16. Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study). Full Text available with Trip Pro

Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study). The aim of this study was to assess public acceptance of four possible healthcare policies supporting tobacco dependence treatment in line with the Framework Convention for Tobacco Control, Article 14 recommendations in Germany.Cross-sectional household survey.Data were drawn from the German population and collected through computer (...) diseases (OR 0.74, 95% CI 0.60 to 0.91) and free provision of treatment (OR 0.80, 95% CI 0.66 to 0.97). Offering cessation treatment to smokers with physical disorders was generally more accepted than to those with mental health issues.The majority of the German population supports healthcare policies to improve the availability and affordability of tobacco dependence treatment. Non-smokers were more supportive than current smokers of two of the four policies, but odds of support were only about 40

2019 BMJ open

17. Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001-2014. Full Text available with Trip Pro

Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001-2014. Analysis of Medicare data is often used to determine epidemiology, healthcare utilization and effectiveness of disease treatments. We were interested in whether Medicare data could be used to estimate prevalence of tobacco use. Currently, data regarding tobacco use is derived from Behavioral Risk Factor Surveillance System (BRFSS) survey data. We compare administrative claims data for tobacco (...) diagnosis among Medicare beneficiaries to survey (BRFSS) estimates of tobacco use from 2001 to 2014.Retrospective cross-sectional study comparing tobacco diagnoses using International Classification of Disease, Ninth Revision (ICD-9) codes for tobacco use in Medicare data to BRFSS data from 2001 to 2014 in adults age ≥ 65 years. Beneficiary data included age, gender, race, socioeconomic status, and comorbidities. Tobacco cessation counselling was also examined using Healthcare Common Procedure Coding

2019 BMC health services research

18. Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness

Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness | CADTH.ca Find the information you need Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness (...) reporting no difference and one study reporting higher rates of abstinence for those on NRT. Tags bupropion, nicorette, nicotine, nicotine patch, tobacco use cessation products, wellbutrin, addiction, Champix, Chantix, Zyban, nicotine gum, nicotine patches, nicotine replacement, nicotine replacements, varenicline Files Rapid Response Summary with Critical Appraisal Published : March 8, 2016 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

19. Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature Full Text available with Trip Pro

Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature Programmed death ligand 1 (PD-L1) targeting immunotherapies, as pembrolizumab and nivolumab, have significantly improved outcome in patients with non-small cell lung cancer (NSCLC). Tobacco smoking is the number one risk factor for lung cancer and is linked to 80%-90% of these cancers. Smoking during cancer therapy may influence on radiotherapy and chemotherapy outcome. We aimed (...) to review the knowledge in immunotherapy.A systematic review was done. We searched for documents and articles published in English language and registered in Cochrane Library, National Health Service (NHS) Centre for Reviews and Dissemination (CRD), Embase or Medline. The search terms were (A) (Lung cancer or NSCLC) with (pembrolizumab or nivolumab) with PD-L1 with (tobacco or smoking) and (B) Lung Neoplasms and Immunotherapy and (smoking cessation or patient compliance). 68 papers were detected and two

2018 ESMO open

20. WITHDRAWN: Reduction versus abrupt cessation in smokers who want to quit. Full Text available with Trip Pro

WITHDRAWN: Reduction versus abrupt cessation in smokers who want to quit. The standard way to stop smoking is to quit abruptly on a designated quit day. A number of smokers have tried unsuccessfully to quit this way. Reducing smoking before quitting could be an alternative approach to cessation. Before this method is adopted it is important to determine whether it is at least as successful as abrupt quitting.1. To compare the success of reducing smoking to quit and abrupt quitting interventions (...) . 2. To compare adverse events between arms in studies that used pharmacotherapy to aid reduction.We searched the Cochrane Tobacco Addiction Review Group specialised register using topic specific terms. The register contains reports of trials of tobacco addiction interventions identified from searches of MEDLINE, EMBASE and PsycInfo. We also searched reference lists of relevant papers and contacted authors of ongoing trials. Date of most recent search: July 2012.We included randomized controlled

2019 Cochrane

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>